Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for augmenting an immune response using anti-CD40 antibodies

Methods for augmenting an immune response using anti-CD40 antibodies

US Patent 7824683 · Granted Nov 2, 2010

Estimated economic value: $13,658,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific binding proteins that bind CD40 and mesothelin2019
Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates2016
Anti-CD70 antibody and its use for the treatment of cancer and immune disorders2015
Treatment of immune disorders with anti-CD70 antibody2014
Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates2013
Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and2013
Methods of treating drug-resistant cancers2013
Anti-CD70 antibody and its use for the treatment and prevention of cancer and im2012
Methods of treating neoplastic, autoimmune and inflammatory diseases2010
Methods for the treatment of cancer using anti-CD40 antibodies2010
Methods for the treatment of cancer using anti-CD40 antibodies2010
Methods for the treatment of cancer using anti-CD40 antibodies2010